NCT06121271 2023-12-07Trial of Lu-177 DOTATATE (Lutathera®) in Unlicensed IndicationsUniversity College, LondonPhase 2 Not yet recruiting110 enrolled
NCT05894486 2023-06-08Phase II Study to Evaluate the Efficacy and Safety of 177Lu-Dotatate in the First-line Treatment of Patients With Locally Advanced or Metastatic, Somatostatin Receptor-positive G2 or G3 Gastroenteropancreatic Neuroendocrine TumorsPeking UniversityPhase 2 Not yet recruiting40 enrolled